BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9041151)

  • 1. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
    Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
    Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors.
    Kaino M; Kondoh S; Okita S; Hatano S; Shiraishi K; Kaino S; Okita K
    Pancreas; 1999 Apr; 18(3):294-9. PubMed ID: 10206488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors.
    Usui H; Otani T
    Pancreas; 2001 Jan; 22(1):108-9. PubMed ID: 11138964
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.
    Kobayashi N; Inamori M; Fujita K; Fujisawa T; Fujisawa N; Takahashi H; Yoneda M; Abe Y; Kawamura H; Shimamura T; Kirikoshi H; Kubota K; Sakaguchi T; Saito S; Saubermann LJ; Nakajima A
    J Hepatobiliary Pancreat Surg; 2008; 15(2):169-77. PubMed ID: 18392710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
    Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
    Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL
    Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
    Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
    Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
    Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
    Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
    Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
    Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer.
    Iguchi H; Sugano K; Fukayama N; Ohkura H; Sadamoto K; Ohkoshi K; Seo Y; Tomoda H; Funakoshi A; Wakasugi H
    Gastroenterology; 1996 Jan; 110(1):221-6. PubMed ID: 8536860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases.
    Ren YX; Xu GM; Li ZS; Song YG
    World J Gastroenterol; 2004 Mar; 10(6):881-4. PubMed ID: 15040037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms.
    Mizuno O; Kawamoto H; Yamamoto N; Horiguchi S; Tsutsumi K; Fujii M; Kato H; Hirao K; Kurihara N; Ishida E; Ogawa T; Okada H; Yamamoto K
    Pancreas; 2010 Jul; 39(5):617-21. PubMed ID: 20173673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
    Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.